Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis

Christopher Em Griffiths; Helen Young; Angela Summers; Paul Brenchley

doi:10.1016/j.jaad.2003.10.510

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Chapter in a book1998

Lesional Levels of Endothelial Cell Stimulating Angiogenesis Factor (ESAF) and Vascular Endothelial Cell Stimulating Angiogenesis Factor (VEGF) are Elevated in Psoriasis

B. McLaughlin, M. Bushan, J B Weiss, Christopher Em Griffiths

Article1999

Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis

M. Bhushan, B. McLaughlin, J B Weiss, Christopher Em Griffiths

Article2009

Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms

Johanna Lähteenvuo, Markku Lähteenvuo, Antti Kivelä, Carolina Rosenlew, Annelie Falkevall, Joakim Klar, Tommi Heikura, Tuomas T. Rissanen, Elisa Vähäkangas, Petra Korpisalo, Berndt Enholm, Peter Carmeliet, Kari Alitalo, Ulf Eriksson, Seppo Ylä‐Herttuala

Letter2001

Vascular endothelial growth factor: angiogenesis, atherogenesis or both?

Jozef Dulak, Alicja Józkowicz, Matthias Frick, Hannes Alber, Wolfgang Dichtl, Severin P. Schwarzacher, Otmar Pachinger, Franz Weidinger

Article2000

Atorvastatin therapy reduces vascular endothelial growth factor (VEGF) in patients with coronary artery disease

Hannes Alber, Jozef Dulak, Severin P. Schwarzacher, Otmar Pachinger, Franz Weidinger